http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20100091212-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-96411 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57423 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57419 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57473 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2008-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e90c8de9081b0df23ba889110e41a6a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c99c9d43520edea72dd7178e84c6527 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_348c0d72a2e01c15ca60ea8380cc0d91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59c4b8bc33a1a073a13ba86a356a022e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7a823d90892128c3254eb73490dd4e1 |
| publicationDate | 2010-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20100091212-A |
| titleOfInvention | Sepprase as a Cancer Marker |
| abstract | The present invention relates to a method for assisting cancer evaluation. The present invention describes the use of human fibroblast activating protein (FAP / seprase) as a universal marker of different cancer types. Sepprases assist in the evaluation of lung or lung cancer (LC) or colon cancer, such as non-small cell lung carcinoma (NSCLC) or colorectal cancer (CRC), but also cancers that may be other specific types of cancer. Such specific cancer types are for example esophageal cancer, head and neck cancer, gastric cancer, bile duct cancer, pancreatic cancer, kidney cancer, cervical cancer, ovarian cancer, breast cancer, bladder cancer, endometrial cancer or prostate cancer. Moreover, the present invention relates, in particular, to a method of assessing cancer from a liquid sample by measuring seprases in a liquid sample derived from an individual. The measurement of seprase can be used, for example, for early detection of cancer or for surveillance of patients undergoing surgery. |
| priorityDate | 2007-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 627.